Kaplan-Meier survival probability plots (with 95% CI shaded) of branded drug product switchbacks over the follow-up period in exposure groups in the primary cohort Figure 4 – Kaplan-Meier survival probability plots
Business Intelligence on Biologic and Small Molecule Drugs